Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-10-14 4:05 pm Unchanged | 2025-10-07 | 13G | Salarius Pharmaceuticals, Inc. SLRX | C/M Capital Master Fund, LP | 0 0.000% | 0 (Unchanged) | Filing History |
| 2025-08-07 4:38 pm Purchase | 2025-08-06 | 13G | Auddia Inc. AUUD | C/M Capital Master Fund, LP | 35,618 5.400% | 35,618 (New Position) | Filing History |
| 2025-07-31 7:16 pm Purchase | 2025-07-28 | 13G | Heritage Distilling Holding Company, Inc. IPST | C/M Capital Master Fund, LP | 2,217,872 9.200% | 2,217,872 (New Position) | Filing History |
| 2025-07-28 5:25 pm Purchase | 2025-07-24 | 13G | Forward Industries, Inc. FORD | C/M Capital Master Fund, LP | 114,975 9.300% | 114,975 (New Position) | Filing History |
| 2025-05-28 5:59 pm Purchase | 2025-05-20 | 13G | Biodexa Pharmaceuticals Plc BDRX | C/M Capital Master Fund, LP | 175,239,000 6.800% | 175,239,000 (New Position) | Filing History |
| 2025-02-18 4:30 pm Unchanged | 2025-02-10 | 13G | Biodexa Pharmaceuticals Plc BDRX | C/M Capital Master Fund, LP | 0 0.000% | 0 (Unchanged) | Filing History |